Convalescent Plasma for Patients With COVID-19: A Pilot Study

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

July 28, 2020

Study Completion Date

July 28, 2020

Conditions
CoronavirusCoronavirus Infection
Interventions
DRUG

Plasma

Day 1: CP-COVID19, 250 milliliters. Day 2: CP-COVID19, 250 milliliters.

Trial Locations (1)

11100

Universidad del Rosario, Bogota

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

CES University

OTHER

collaborator

Instituto Distrital de Ciencia Biotecnologia e Innovacion en salud

UNKNOWN

collaborator

Fundación Universitaria de Ciencias de la Salud

OTHER

lead

Universidad del Rosario

OTHER